InflaRx NV (IFRX)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

WINZERLAER STR. 2 JENA, GERMANY 07745

InflaRx N.V. operates as a clinical-stage biopharmaceutical company. The Company discovers and develops monoclonal antibodies drugs for the treatment of inflammatory diseases. InflaRx serves patients worldwide.

Data based on most recent fiscal year report
Market Cap669.994 Million Shares Outstanding23.41 Million Avg Volume39.224 Thousand
1-Yr BETA vs S&P TR0.755 Current Ratio16.84 Quick Ratio16.84
View SEC Filings from IFRX instead.
Q2 2019 All Institutions Hedge Funds 1
To trade IFRX now:
Filers who had this stock in their top 10: 0 0 (0.0%)
13F Filers holding this stock: 30 9 (0.93%)
Aggregate 13F shares on 06/30/2019: 4.43 Million 2.764 Million
Aggregate 13F shares on 03/31/2019: 14.509 Million 10.831 Million
Percent change: -69.47% -74.48%
Funds creating new positions: 13 3
Funds Adding to an existing position: 8 4
Funds closing out their position: 30 12
Funds reducing their position: 7 2
1 hedge funds as identified by whalewisdom.com through public filings.

Funds Holding IFRX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Click here to report any possible errors with this stock listing.

Elevate your investments